Imidazolyl-(2)-thio-alkanoic acid esters
    1.
    发明授权
    Imidazolyl-(2)-thio-alkanoic acid esters 失效
    咪唑基 - (2) - 硫代链烷酸酯

    公开(公告)号:US3915980A

    公开(公告)日:1975-10-28

    申请号:US42160373

    申请日:1973-12-04

    Applicant: HOECHST AG

    CPC classification number: C07D233/84

    Abstract: Imidazolyl-(2)-thioalkanoic acid ester of the formula I

    in which R stands for phenyl, phen-(C1-C3)alkyl, R1 stands for hydrogen or (C1-C3)-alkyl and R2 and R3 each stands for (C1-C3)-alkyl, AND THE PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM AS ACTIVE SUBSTANCE.

    Abstract translation: 式I的咪唑基 - (2) - 硫代链烷酸酯,其中R代表苯基,苯 - (C1-C3)烷基,R1代表氢或(C1-C3) - 烷基,R2和R3各自代表(C1 -C 3) - 烷基,以及生理学上可接受的酸添加剂,其制备方法及其作为活性物质的药物制剂。

    N-phenyl-carbamic acid-{8 imidazolyl-(1)-methyl{9 {0 esters
    2.
    发明授权
    N-phenyl-carbamic acid-{8 imidazolyl-(1)-methyl{9 {0 esters 失效
    N-苯基 - 氨基甲酸 - {8-咪唑基 - (1) - 甲基{9 {0酯

    公开(公告)号:US3915984A

    公开(公告)日:1975-10-28

    申请号:US42286173

    申请日:1973-12-07

    Applicant: HOECHST AG

    CPC classification number: C07D235/06 C07D231/12 C07D233/56 C07D249/08

    Abstract: Compounds of the formula

    IN WHICH R1 and R2 each stands for a hydrogen atom or together they stand for the group -CH CH-CH CH- which may carry one or more lower alkyl, halogeno-alkyl or alkoxy groups, halogen atoms or NO2-groups, and R3 and R4, independently of one another, each stands for a hydrogen atom, a lower alkyl, halogeno-alkyl, alkoxy or halogeno-alkoxy group, a halogen atom or NO2 or together they stand as a -CH CH-CH CH- group with the benzene nucleus for the naphthyl group, AND PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE SUBSTANCE.

    Abstract translation: 式Ⅰ的化合物,其中R 1和R 2各自代表氢原子,或一起代表基团-CH = CH-CH = CH-,其可以携带一个或多个低级烷基,卤代烷基或烷氧基,卤素原子或 NO 2 - 基,R 3和R 4彼此独立地表示氢原子,低级烷基,卤代 - 烷基,烷氧基或卤代 - 烷氧基,卤素原子或NO 2,或者一起表示-CH = CH-CH = CH-基团与萘基的萘基,以及生理学上可接受的酸加法盐,其制备它们和作为活性物质的药物组合物的方法。

Patent Agency Ranking